Brice L Gauilliere

Title: Brice L Gauilliere: Innovator in Preeclampsia Prognosis

Introduction

Brice L Gauilliere is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of medical research, particularly in the area of preeclampsia. His innovative work focuses on the prognosis and classification of this pregnancy-related condition.

Latest Patents

Brice L Gauilliere holds a patent for "Compositions and methods of prognosis and classification for preeclampsia." This patent involves a multiparametric analysis performed at the single-cell level of biological samples obtained from individuals during pregnancy. The analysis aims to determine changes in immune cell subsets, including altered activation states of proteins involved in signaling pathways. These changes in immune cell signaling pathways are predictive of the propensity to develop preeclampsia during pregnancy. He has 1 patent to his name.

Career Highlights

Brice L Gauilliere is affiliated with Leland Stanford Junior University, where he conducts his research. His work has garnered attention for its potential to improve the understanding and management of preeclampsia, a condition that can have serious implications for both mothers and infants.

Collaborations

Brice collaborates with esteemed colleagues, including Martin S Angst and Nima Aghaeepour. Their combined expertise enhances the research efforts in understanding preeclampsia and its underlying mechanisms.

Conclusion

Brice L Gauilliere's innovative contributions to the field of preeclampsia prognosis highlight the importance of research in improving maternal and fetal health. His work exemplifies the impact of scientific innovation on real-world medical challenges.